Collaboration award
Biomedica summit award launched to promote industry-academia collaborations!
Submissions are open ! Send your summary to liege2012@biomedicasummit.eu before March 1, 2012
Collaborating companies and academic institutes/universities will be rewarded for innovative application oriented research or projects in the field of life sciences, medical technology or red and white biotechnology. The award aims to accelerate the transfer of scientific knowledge into market applications.
The Biomedica summit Award will be granted for the first time during the 6th Biomedica Summit.
Criteria:
The award will be judged on the following criteria:
- Clear description of how the collaborative model brought value to the academic partner as well as to the industrial partner
- Value created through use of collaboration
- Degree of Innovation, new products, concepts or processes
- Potential market applications and market implementation
- Overall performance
- The collaboration should have started in 2005 or thereafter.
- Company AND/OR academic institute should be located in The Netherlands, North-Rhine Westphalia or Belgium.
- Applying for the award does not entitle to free registration to the Summit
Prize:
10.000 € will be provided as a one-time payment to be shared between the academic institute and the industrial partner. Taxes are included.
Award presentation:
Award presentations by nominees will take place on April 18, 2012 during the 6th Biomedica summit held at the Palais de Congres in Liège. The Formal award will be granted on Thursday April 19, 2012.
Jury:
| CHAIR | |
| Prof. Dr. Bernard Rentier | Chair Foundation Biomedica |
| Rector University of Liège, Belgium | |
| MEMBERS | |
| Dr. Rob Gossink | Chairman of the supervisory board, University hospital, Aachen, Germany |
| Former director of Philips research, Germany | |
| Former chair of Lifetec Aachen-Jülich | |
| Mr. Jos Nelissen | Director Newtricious BV, Oirlo, The Netherlands |
| Emeritus. Prof. Dr. Joseph Martial | Chair of GIGA, University of Liège, Belgium, |
| Chairman of the board of directors of Diagenode SA | |
| Founder of Eurogentec | |
| Mr. John Vossen | Investment Manager Limburg Ventures, Maastricht, The Netherlands |
General rules/information:
- Self-nominations are acceptable
- After you have sent your summary, the committee may contact you for additional information required for the nomination(s).
- A summary in English language with regard to the project description including a description showing that the mentioned criteria are met, should be mailed to liege2012@biomedicasummit.eu before March 1, 2012
- Summaries exceeding more than 3 A4 pages (Times New Roman 11 - Word document) will be rejected.
Disclosure:
Participation in the Biomedica summit award means that the participant allows Biomedica Foundation to make public wholly or in part any (project) detail being provided to Biomedica Foundation and or to its partners. Participation also allows publications of provided information for award ceremony or publicity purposes or use on Biomedica summit website.
The Biomedica Foundation has no obligation to provide financial compensation. Participation in the Biomedica summit award does not imply thatownership of an entry is transferred to Biomedica.
